Teva names interim CEO, new chairman as Vigodman steps down

Teva names interim CEO, new chairman as Vigodman steps down


Feb 6 Israel-based generic drugmaker Teva Pharmaceutical Industries Ltd said on Monday that Chief Executive Erez Vigodman was stepping down effective immediately and would be replaced on an interim basis by Yitzhak Peterburg, who has been chairman of Teva's board of directors. Because Israeli company law calls for separation of the roles of chairman and CEO, Petersburg will no longer head the board, which elected former Celgene Corp CEO Sol Barer to serve as the new chairman of the world's largest seller of generic medicines.



from Biotech News